Literature DB >> 1861546

Effect of (dl)-5-methyltetrahydrofolate on lymphoid leukemia cell lines.

P A Bernabei1, W I Bensinger.   

Abstract

We studied the effect of (dl)-5-methyltetrahydrofolate (mTHF) on the lymphoid cell lines BALM 3, CCRF-SB, CEM, Daudi, MOLT 4 and P3HR1, employing doses in the mM range. The growth of all the lines studied was inhibited by mTHF in a dose-dependent fashion. mTHF demonstrated a substantial cytocidal effect on leukemic lymphoid cells of up to 3 log, as measured by limiting dilution analysis, at a concentration of 10(-3) M. At this dose normal human lymphocyte viability was not affected, and their mitogen-induced proliferation was only slightly impaired. We tested the effect of high doses of mTHF on a clone of CEM cells (CEM-MTXr) infected with the pSDHT retrovirus able to transduce a dominant-acting gene encoding a mutant, less efficient, dihydrofolate reductase. CEM-MTXr cells were inhibited by high doses of mTHF to the same degree as the parental line, thus suggesting that the enzymatic reactions leading to folate reduction are not involved in the cytocidal effect of mTHF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861546     DOI: 10.1016/0145-2126(91)90034-q

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer.

Authors:  R M Mader; G G Steger; B Rizovski; M P Djavanmard; W Scheithauer; R Jakesz; H Rainer
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

2.  Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.

Authors:  Maria Grazia Cipolleschi; Ilaria Marzi; Roberta Santini; David Fredducci; Maria Cristina Vinci; Massimo D'Amico; Elisabetta Rovida; Theodora Stivarou; Eugenio Torre; Persio Dello Sbarba; Barbara Stecca; Massimo Olivotto
Journal:  Cell Cycle       Date:  2013-11-05       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.